The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the etiological agent for the Coronavirus Disease 2019 (COVID‐19). The COVID‐19 pandemic has created …
P Vellanki, GE Umpierrez - The Lancet Diabetes & Endocrinology, 2021 - thelancet.com
Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes. DKA most often occurs in people with type 1 diabetes, but can also …
A Sen, A Nigam, M Vachher - International Journal of Peptide Research …, 2022 - Springer
Abstract The COVID-19 (coronavirus disease 2019) pandemic that took over the world in December 2019 has had everlasting devastating impacts on the lives of people globally. It …
V Moreno-Torres, E Sanchez-Chica… - Annals of Palliative …, 2022 - apm.amegroups.org
Background: Red blood cell distribution width (RDW) could reflect interleukin-6 (IL-6) systemic activity since anisocytosis represents the inhibition of erythropoiesis, leaded by the …
JA Martínez, M Alonso-Bernáldez… - World Journal of …, 2022 - ncbi.nlm.nih.gov
The liver is a key organ involved in a wide range of functions, whose damage can lead to chronic liver disease (CLD). CLD accounts for more than two million deaths worldwide …
A Cuevas-Sierra, L Chero-Sandoval, A Higuera-Gómez… - Iscience, 2024 - cell.com
Patients with Post-viral long hauler encompass lasting symptoms and comorbid complexities, often exacerbated in individuals with excessive body weight. The aim was to …
M Alonso-Bernáldez, A Cuevas-Sierra, V Micó… - Antioxidants, 2023 - mdpi.com
Viral infections activate the innate immune response and the secretion of inflammatory cytokines. They also alter oxidative stress markers, which potentially can have an …
O Ramos-Lopez, R San-Cristobal… - Journal of Clinical …, 2021 - mdpi.com
Objective: to screen putative associations between liver markers and proinflammatory- related features concerning infectious morbidity and fatal outcomes in COVID-19 patients …
R San-Cristobal, R Martín-Hernández… - Journal of Clinical …, 2022 - mdpi.com
The use of routine laboratory biomarkers plays a key role in decision making in the clinical practice of COVID-19, allowing the development of clinical screening tools for personalized …